class action

Explore a wealth of information related to class action lawsuits, a crucial aspect of collective legal action where a group of individuals comes together to sue a defendant. Visitors will find insightful articles, detailed explanations of legal terms, and video interviews with attorneys discussing the nuances of class action cases. This section serves as a comprehensive resource for understanding the legal processes, eligibility criteria, and potential outcomes associated with class actions in the United States.

Watch: Lawyer Explains Criteria for Taking on Personal Injury Claims

How to Enforce Your Right to Opt Out of AI Model Training Using Illinois Biometric Data Under BIPA in 2026

Artificial Intelligence Rights /

Illinois residents can seek statutory damages of $1,000 per negligent violation and $5,000 per reckless/intentional violation under the Biometric Information Privacy Act (BIPA). In 2026, that leverage increasingly applies to AI systems trained on “biometric identifiers” or “biometric information,” including face geometry extracted from images and videos. This guide explains how to opt out, preserve […]

How to Enforce Your Right to Opt Out of AI Model Training Using Illinois Biometric Data Under BIPA in 2026 Read More »

Mass tort product liability cases roundup

The Mass Tort Round-Up – Which Product Cases You Can Still Join

Consumer Protection, Health and Medical Issues, Legal Information, Personal Injury Law, Product Liability /

Many active mass tort product cases are still open to new claimants, but eligibility often depends on filing deadlines, diagnosis timing, and proof of product exposure. These group lawsuits target widely used products—such as medications, medical devices, and consumer goods—linked to serious injuries, and missing a statute of limitations can bar recovery. This article rounds

The Mass Tort Round-Up – Which Product Cases You Can Still Join Read More »

CVS Fails to Preempt False Ad Lawsuit

CVS False Advertising Lawsuit: Preemption Bid Fails in ‘Non-Drowsy’ Case

Business Law, Civil Litigation, Commercial Law, Consumer Protection, Corporate Law, Federal Law, Legal Liability, Personal Injury, Tort Law, Trial Procedures, Trial Process /

A federal judge denied CVS’s bid to dismiss a false advertising lawsuit claiming its “Non-Drowsy” product labeling misleads consumers. The court found the plaintiff’s state-law claims were not preempted by federal drug-labeling rules at this stage. This article explains the ruling, the preemption arguments, what “non-drowsy” claims must prove in litigation, and what the case

CVS False Advertising Lawsuit: Preemption Bid Fails in ‘Non-Drowsy’ Case Read More »

Scroll to Top